ASPIVIX Reports Positive First-in-Women Results Using Novel Suction-based Cervical Device in IUD Procedures

RENENS, Switzerland, Dec. 10, 2020 /PRNewswire/ — ASPIVIX SA, a developer of medical technologies to advance gynecological care, today announced completion of and interim analysis results from its Phase I first-in-women trial. The ADVANCE Women (Atraumatic Device using VAcuum Technology…

About the Author

has written 41802 stories on this site.

Copyright © 2010 Business and Corporate News.